China Just Approved A New Weight-Loss Drug, And American Utility Firms Are Powering Up On Infrastructure Spending

China just approved a local drugmaker’s weight-loss medicine, effectively ending Novo Nordisk and Eli Lilly’s two-horse race, while US utility firms are set to make record infrastructure investments – but Big Tech may still go entirely off-grid.Today’s stories:Novo Nordisk And Eli Lilly Have A Rival In The Weight-Loss Drug FightAmerica’s Utility Firms Are Powering Up Their Infrastructure SpendingTry Finimize Pro